Artemida Pharma is a specialist consultancy business established by a group of drug development experts, to provide strategic drug development consultancy and project management to start-up, biopharma and mid-sized pharma companies. We are a provider of end-to-end services, encompassing strategic clinical, regulatory and commercial expertise, along with a focus on technical pharmaceutical development of small molecules and biological agents.

Our advice is independent and pragmatic. We work with our clients, complementing their skill-sets and resources, to help them in overcoming obstacles in their drug development pathways.

Artemida Pharma is a member of the Oslo Cancer Cluster.